U.S. flag

An official website of the United States government

NM_000104.4(CYP1B1):c.319C>G (p.Leu107Val) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 13, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002265688.1

Allele description [Variation Report for NM_000104.4(CYP1B1):c.319C>G (p.Leu107Val)]

NM_000104.4(CYP1B1):c.319C>G (p.Leu107Val)

Gene:
CYP1B1:cytochrome P450 family 1 subfamily B member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p22.2
Genomic location:
Preferred name:
NM_000104.4(CYP1B1):c.319C>G (p.Leu107Val)
HGVS:
  • NC_000002.12:g.38075070G>C
  • NG_008386.2:g.6032C>G
  • NM_000104.4:c.319C>GMANE SELECT
  • NP_000095.2:p.Leu107Val
  • NP_000095.2:p.Leu107Val
  • NC_000002.11:g.38302213G>C
  • NM_000104.3:c.319C>G
Protein change:
L107V
Links:
dbSNP: rs56339482
NCBI 1000 Genomes Browser:
rs56339482
Molecular consequence:
  • NM_000104.4:c.319C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002547828Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(May 13, 2022)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

CYP1B1 gene mutations with incomplete penetrance in a Chinese pedigree with primary congenital glaucoma: a case report and review of literatures.

Chen L, Huang L, Zeng A, He J.

Int J Clin Exp Med. 2015;8(8):14538-41.

PubMed [citation]
PMID:
26550445
PMCID:
PMC4613130

CYP1B1 genotype influences the phenotype in primary congenital glaucoma and surgical treatment.

Chen X, Chen Y, Wang L, Jiang D, Wang W, Xia M, Yu L, Sun X.

Br J Ophthalmol. 2014 Feb;98(2):246-51. doi: 10.1136/bjophthalmol-2013-303821. Epub 2013 Nov 13.

PubMed [citation]
PMID:
24227805
See all PubMed Citations (7)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002547828.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

Variant summary: CYP1B1 c.319C>G (p.Leu107Val) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00034 in 196756 control chromosomes, predominantly at a frequency of 0.0042 within the East Asian subpopulation in the gnomAD database. This frequency similar to the expected for a pathogenic variant in CYP1B1 causing Primary Congenital Glaucoma (0.00034 vs 0.0043), suggesting the variant might be a polymorphism found in the East Asian population. c.319C>G has been reported in the literature in individuals affected with Primary Congenital Glaucoma without strong evidence for causality, as well as in controls and unaffected individuals (eg. Chen_2008, Kim_2011, Chen_2014, Chen_2015, Gong_2015, Qiao_2021). These reports do not provide unequivocal conclusions about association of the variant with Primary Congenital Glaucoma. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Three submitters classified the variant as VUS while one classified as benign. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024